Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect information about the antitumor activity and the
safety of capecitabine and thalidomide in patients with colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital